Results 171 to 180 of about 438,216 (309)

Correction: Impact of chemoradiotherapy for bladder cancer on pre-existing hydronephrosis and development of new hydronephrosis. [PDF]

Radiat Oncol
Remmelink MJ, El Awadly N, Arbeel-Weening B, Nadorp S, Leter MR, Oddens JR, Brück K, Nieuwenhuijzen JA, Bins AD.   +8 more
europepmc   +1 more source

Inflammatory bowel disease and metabolic reprogramming: From pathological mechanisms to targeted interventions

Interdisciplinary Medicine, EarlyView.
This review explores the role of metabolic reprogramming in inflammatory bowel disease (IBD) by focusing on immune and epithelial cell metabolism, microbial metabolites, and their impact on inflammation. It discusses emerging metabolic therapies and emphasizes the importance of personalized microbiota‐targeted approaches to improve clinical outcomes in
Zemin Tian, Yinde Huang, Ying Wang, Chenyu Zhao, Zhaokai Zhou, Hua Yang, Yuan Qiu   +6 more
wiley   +1 more source

What’s Up in Urology Journal, Spring 2011?

Urology Journal, 2011
Urology Journal
doaj  

Childhood urinary symptoms. Do they “predict” urinary problems in young adult women? [PDF]

, 2016
Balsamo R, Bini V, Costantini E, Filocamo MT, Giannitsas K, Illiano E., MaruccIa S, Natale F, PALLESCHI, GIOVANNI, PASTORE, ANTONIO LUIGI, Porena M, Villari D   +11 more
core  

The diagnosis of venogenic impotence [PDF]

, 1988
Bosch, Ruud J. L. H., Bénard, Francois, Diederichs, W., Lue, Tom F., Stief, Christian Georg, Tanagho, Emil A.   +5 more
core   +1 more source

Urological Reflections [PDF]

Proceedings of the Royal Society of Medicine, 1946
openaire   +2 more sources

41 years of Indian Journal of Urology: Reflections for 2025. [PDF]

Indian J Urol
Goel A.
europepmc   +1 more source

Population Pharmacokinetics Analysis of Talazoparib and Enzalutamide Combination Therapy for Patients With Metastatic Castration‐Resistant Prostate Cancer

The Journal of Clinical Pharmacology, EarlyView.
Abstract The poly(ADP‐ribose) polymerase inhibitor talazoparib, combined with the androgen receptor inhibitor enzalutamide is approved for patients with homologous recombination repair (HRR) gene‐mutated metastatic castration‐resistant prostate cancer (mCRPC) in the US and with mCRPC in whom chemotherapy is not clinically indicated in Europe.
Mark Hadigol, Jason H. Williams, Haihong Shi, Derek Z. Yang, Justin Hoffman, Diane D. Wang   +5 more
wiley   +1 more source

What’s Up in Urology Journal, Spring 2010?

Urology Journal, 2010
Urology Journal
doaj  

A case of retroperitoneal giant leiomyoma and literature review. [PDF]

Ther Adv Urol
Lai Z, Shi X, Wang Q, Lalani S, Wang Y, Lian Y, Zheng Z, Huang W, Pang S, Tan W.   +9 more
europepmc   +1 more source